Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07116096

Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis

1. Background Handgrip strength , a core indicator of muscle function, has been confirmed to be significantly associated with the clinical prognosis of patients with liver cirrhosis. However, no studies have explored its correlation with portal venous hemodynamics. 2. Objective The purpose of the study is to examine the effects of Handgrip strength on portal vein and left gastric vein pressure, blood flow velocity and direction in patients with liver cirrhosis, as well as its hemodynamic impact on gastroesophageal varices. 3. Method Study Design: Interventional study. Detection Timing: Hemodynamic indices were measured simultaneously after patients achieved their maximum handgrip strength. Participants were divided into three groups based on the assessment methods. Group 1 (Portal Pressure Measurement Group): Before the placement of TIPS, the pressures of the portal vein and left gastric vein were measured, both before and after the handgrip strength test. Group 2 (Doppler Ultrasound Measurement Group): Measurements of portal flow velocity and direction were taken before and after the handgrip strength test, based on Doppler ultrasound. Group 3 (Endoscopic Ultrasound Measurement Group): Measurements of blood flow volume and direction in esophagogastric varices were conducted before and after the handgrip strength test, based on endoscopic ultrasonography. The inclusion and exclusion criteria were described. 4. Elaboration of the Research Hypothesis 4.1. Core Hypothesis The handgrip strength level in patients with liver cirrhosis is correlated with portal venous system hemodynamic indices. Specifically, enhanced handgrip strength may affect portal hypertension and the hemodynamics of varicose veins by improving systemic muscle function or circulatory status.

4.2. Speculation on potential mechanisms Association between muscle function and circulation: As a representative of systemic muscle function, increased handgrip strength may reflect an increase in cardiac output or changes in splanchnic vascular resistance, thereby influencing portal venous hemodynamics.

Effects on varicose veins: Improved handgrip strength may reduce blood flow velocity or diameter of esophagogastric varices by decreasing splanchnic congestion or regulating local vascular tension, thus lowering the risk of variceal rupture and bleeding.

Role of compensatory mechanisms: Muscle wasting is common in decompensated cirrhosis. Patients with higher handgrip strength may have better compensatory capacity, and the degree of hemodynamic disorder in their portal venous system may be less severe.

Conclusion This study uses a multi-method grouping design to first explore the association between handgrip strength and portal venous hemodynamics in cirrhotic patients. The hypothesis is based on the potential regulatory role of muscle function in the circulatory system, which is expected to provide a new non-invasive indicator for clinical assessment of portal hypertension risk.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged ≥18 years old
  • Clinically diagnosed with liver cirrhosis
  • Endoscopic observation to determine the presence of esophagogastric varices
  • Only eligible for the portal vein pressure measurement group if there are no signs of variceal bleeding for at least 14 days
  • Participant or guardian is capable of comprehending the study protocol, willing to participate, and able to provide written informed consent

Exclusion criteria

  • Severe congestive heart failure, or severe untreated valvular heart disease
  • Moderate to severe pulmonary hypertension
  • Uncontrolled systemic infection
  • Lesions (e.g., cysts) or tumors in the liver parenchyma that preclude TIPS creation
  • Overt hepatic encephalopathy
  • Unrelieved biliary obstruction
  • Child-Pugh score > 13
  • MELD score > 18
  • INR > 5
  • Platelet count < 20 ×109/mm3
  • No gastrointestinal bleeding (suitable for the ultrasound examination group and the endoscopic ultrasonography group)
  • Participants who had undergone hand or wrist surgery within the previous 3 months or were unable to hold the dynamometer with the testing hand were excluded from the study.

Treatment and study plan

Jamar Hand Dynamometer, Hand Dynamometer

Device

Jamar Hand Dynamometer, from Illinois, USA. Maximum handgrip strength was measured three times, with each measurement lasting 3 seconds and a 1-minute interval between tests

Primary outcomes

  1. portal pressure

    Time frame: through study completion, an average of 3 minutes

  2. left gastric vein pressure

    Time frame: through study completion, an average of 3 minutes

  3. portal flow velocity

    Time frame: Before the handgrip strength test, and during the maximum handgrip strength phase, measurements were conducted at intervals of 15 seconds, 30 seconds, 45 seconds, and 60 seconds after the release of strength related to the HGS

  4. Portal vein blood flow direction

    Time frame: Before the handgrip strength test, and during the maximum handgrip strength phase, measurements were conducted at intervals of 15 seconds, 30 seconds, 45 seconds, and 60 seconds after the release of strength related to the HGS

  5. Blood flow velocity in esophageal varices

    Time frame: through study completion, an average of 3 minutes

  6. Blood flow direction of esophageal varices

    Time frame: through study completion, an average of 3 minutes

  7. Diameter of esophageal varices

    Time frame: through study completion, an average of 3 minutes

  8. Heart rate

    Time frame: through study completion, an average of 3 minutes

  9. blood pressure

    Time frame: through study completion, an average of 3 minutes

Secondary outcomes

  1. Serum albumin

    Time frame: Baseline

  2. Prothrombin time

    Time frame: Baseline

  3. triglyceride

    Time frame: Baseline

  4. Total cholesterol

    Time frame: Baseline

  5. Fasting blood glucose

    Time frame: Baseline

  6. Serum creatinine

    Time frame: Baseline

  7. Platelet count

    Time frame: Baseline

  8. Serum potassium

    Time frame: Baseline

  9. Serum sodium

    Time frame: Baseline

  10. Serum chloride

    Time frame: Baseline

  11. alanine aminotransferase

    Time frame: Baseline

  12. aspartate aminotransferase

    Time frame: Baseline

  13. Total bilirubin

    Time frame: Baseline

  14. height

    Time frame: Baseline

  15. weight

    Time frame: Baseline

Study contacts

Contact information is provided by the study sponsor or research team.

Mingyuan Zhao, M.D.

CONTACT

[email protected]

+86 134 8537 1098

Sponsors and collaborators

Lead sponsor

Shanxi Provincial People's Hospital

Other Gov

Collaborators

  • The First Affiliated Hospital of Henan University of Science and Technology
  • The First Affiliated Hospital of Shanxi Medical University
  • The Third People's Hospital of Taiyuan

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 11, 2025
Registry last updated
Jan 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.